STEADY-STATE PLASMA-LEVELS OF E-10-OH-NORTRIPTYLINE AND Z-10-OH-NORTRIPTYLINE IN NORTRIPTYLINE-TREATED PATIENTS - SIGNIFICANCE OF CONCURRENT MEDICATION AND THE SPARTEINE OXIDATION PHENOTYPE

被引：32

作者：

GRAM, LF ^{[1
]}

BROSEN, K ^{[1
]}

KRAGHSORENSEN, P ^{[1
]}

CHRISTENSEN, P ^{[1
]}

机构：

[1] ODENSE UNIV,SCH MED,DEPT PSYCHIAT,DK-5000 ODENSE C,DENMARK

来源：

THERAPEUTIC DRUG MONITORING | 1989年 / 11卷 / 05期

关键词：

D O I：

10.1097/00007691-198909000-00003

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：508 / 514

页数：7

共 28 条

[11] DRUG INTERACTION - INHIBITORY EFFECT OF NEUROLEPTICS ON METABOLISM OF TRICYCLIC ANTIDEPRESSANTS IN MAN [J].

GRAM, LF ;

OVERO, KF .

BRITISH MEDICAL JOURNAL, 1972, 1 (5798) :463-&

[12]

GRAM LF, 1974, AM J PSYCHIAT, V131, P863

[13]

GRAM LF, 1975, PSYCHOPHARMACOL COMM, V1, P165

[14]

GRAM LF, IN PRESS CLIN PHARM

[15]

GRAM LF, 1984, FRONTIERS BIOCH PHAR, P399

[16]

INABA T, 1985, DRUG METAB DISPOS, V13, P443

[17] SELF-INHIBITING ACTION OF NORTRIPTYLINES ANTIDEPRESSIVE EFFECT AT HIGH PLASMA-LEVELS - RANDOMIZED, DOUBLE-BLIND-STUDY CONTROLLED BY PLASMA CONCENTRATIONS IN PATIENTS WITH ENDOGENOUS-DEPRESSION [J].

KRAGHSORENSEN, P ;

HANSEN, CE ;

BAASTRUP, C ;

HVIDBERG, EF .

PSYCHOPHARMACOLOGIA, 1976, 45 (03) :305-312

[18]

KRAGHSORENSEN P, 1973, LANCET, V1, P113

[19] FACTORS INFLUENCING NORTRIPTYLINE STEADY-STATE KINETICS - PLASMA AND SALIVA LEVELS [J].

KRAGHSORENSEN, P ;

LARSEN, NE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (06) :796-803

[20] E-10-HYDROXYLATION AND Z-10-HYDROXYLATION OF NORTRIPTYLINE - RELATIONSHIP TO POLYMORPHIC DEBRISOQUINE HYDROXYLATION [J].

MELLSTROM, B ;

BERTILSSON, L ;

SAWE, J ;

SCHULZ, HU ;

SJOQVIST, F .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :189-193

← 1 2 3 →